Patients Can Get Faster Lung Cancer Diagnosis, Treatment With HSHS In O'Fallon New Robotic Biopsy System
O’FALLON, Ill. — Time matters – especially when you or a loved one is waiting for the results of a lung cancer biopsy. HSHS St. Elizabeth’s Hospital is now offering the latest leading-edge technology for lung cancer biopsies with the Ion® endoluminal system. The new robotic-assisted procedure can reduce or even eliminate the need for more-invasive lung cancer biopsies or even surgery to determine a cancer diagnosis and subsequent treatment. The result: A faster diagnosis and treatment plan, which can lead to a better survival rate for patients. According to the American Cancer Society, 44% of lung cancer cases are not caught until a late stage when the five-year survival rate is only 8%. If the cancer is caught in an early stage, the survival rate jumps to 63%. “We are excited to equip our pulmonologists with leading edge robotic technology as they care for their patients. This investment in the latest lung screening and therapeutic technology defines
stLouIST